IRINOTECAN HIKMA 20 mg/mL, solution à diluer pour perfusion — 1 flacon(s) en verre de 5 ml

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400955053521
  • CIP7 5505352
  • CIS 69123578

What the source publishes

Holder
HIKMA FARMACEUTICA (PORTUGAL)
Active ingredients
CHLORHYDRATE D'IRINOTÉCAN TRIHYDRATÉ, IRINOTÉCAN
Form
solution à diluer pour perfusion
Package
1 flacon(s) en verre de 5 ml
Routes
intraveineuse
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2018-03-09
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400955053521
{
  "cis": "69123578",
  "cip7": "5505352",
  "form": "solution à diluer pour perfusion",
  "name": "IRINOTECAN HIKMA 20 mg/mL, solution à diluer pour perfusion — 1 flacon(s) en verre de 5 ml",
  "cip13": "3400955053521",
  "holder": "HIKMA FARMACEUTICA (PORTUGAL)",
  "routes": [
    "intraveineuse"
  ],
  "holders": [
    "HIKMA FARMACEUTICA (PORTUGAL)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2018-03-09",
  "compositions": [
    {
      "name": "CHLORHYDRATE D'IRINOTÉCAN TRIHYDRATÉ",
      "nature": "SA",
      "strength": "20 mg",
      "linkageNumber": "1",
      "substanceCode": "20915",
      "dosageReference": "1 mL de solution",
      "pharmaceuticalElement": "solution"
    },
    {
      "name": "IRINOTÉCAN",
      "nature": "FT",
      "strength": "17,33 mg",
      "linkageNumber": "1",
      "substanceCode": "73952",
      "dosageReference": "1 mL de solution",
      "pharmaceuticalElement": "solution"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "IRINOTECAN HIKMA 20 mg/mL, solution à diluer pour perfusion",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 flacon(s) en verre de 5 ml",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2020-11-30",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CHLORHYDRATE D'IRINOTÉCAN TRIHYDRATÉ",
    "IRINOTÉCAN"
  ],
  "authorisationProcedure": "Procédure de reconnaissance mutuelle",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400955053521"